Silvana Sandri Selected Research

Silvana Sandri Research Topics

Disease

5	Neoplasms (Cancer) 12/2023 - 01/2016
5	Melanoma (Melanoma, Malignant) 12/2023 - 01/2016
4	Inflammation (Inflammations) 01/2024 - 05/2008
3	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2016
3	Insulin Resistance 03/2022 - 02/2015
2	Colitis 01/2024 - 01/2021
2	Weight Gain 03/2022 - 01/2016
2	Hypoxia (Hypoxemia) 01/2019 - 10/2013
2	Fibrosis (Cirrhosis) 01/2018 - 01/2018
1	Body Weight (Weight, Body) 03/2022
1	Endotoxemia 03/2022
1	Atherosclerosis 02/2021
1	Atherosclerotic Plaque (Atheroma) 02/2021
1	Peritonitis 01/2021
1	Burns 01/2021
1	Crohn Disease (Crohn's Disease) 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Herpes Zoster 11/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2020
1	Uterine Cervical Dysplasia 09/2020
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2020
1	Lung Diseases (Lung Disease) 01/2018
1	Obesity 01/2016
1	Acute-Phase Reaction 01/2014
1	Necrosis 12/2011
1	Experimental Diabetes Mellitus 06/2010
1	Renal Insufficiency (Renal Failure) 06/2010
1	Infections 05/2008

Drug/Important Bio-Agent (IBA)

4	Serum Amyloid A Protein (Serum Amyloid A)IBA 03/2022 - 05/2008
4	Messenger RNA (mRNA)IBA 03/2022 - 10/2013
3	Annexin A1IBA 01/2023 - 09/2020
3	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 02/2015
3	Proteins (Proteins, Gene)FDA Link 09/2020 - 10/2013
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2021
2	LipopolysaccharidesIBA 01/2021 - 01/2016
2	Phosphates (Orthophosphate)IBA 01/2021 - 06/2010
2	Therapeutic UsesIBA 01/2020 - 01/2019
2	NanocapsulesIBA 01/2019 - 01/2017
2	LipidsIBA 01/2019 - 01/2017
2	caprolactoneIBA 01/2019 - 01/2017
2	ParaquatIBA 01/2018 - 01/2018
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2024
1	Dextrans (Dextran)FDA Link 01/2024
1	decabromobiphenyl ether (decabromodiphenyl ether)IBA 12/2023
1	LeptinIBA 03/2022
1	Insulin (Novolin)FDA Link 03/2022
1	Docosahexaenoic AcidsIBA 02/2021
1	BuffersIBA 01/2021
1	SmokeIBA 01/2021
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2021
1	Infliximab (Remicade)FDA Link 01/2021
1	Dextran SulfateIBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 11/2020
1	Claudin-1IBA 11/2020
1	Mucin-1 (CA 15-3 Antigen)IBA 11/2020
1	Cisplatin (Platino)FDA LinkGeneric 09/2020
1	DNA (Deoxyribonucleic Acid)IBA 09/2020
1	Peptides (Polypeptides)IBA 09/2020
1	DNA AdductsIBA 09/2020
1	Interferon-gamma (Interferon, gamma)IBA 01/2020
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2020
1	Drug CarriersIBA 01/2019
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2019
1	Vitamin D FDA LinkGeneric 01/2018
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2017
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2017
1	acetyleugenolIBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	Interleukin-10 (Interleukin 10)IBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2016
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	Antisense OligonucleotidesIBA 01/2016
1	matrigelIBA 01/2016
1	Tissue Inhibitor of Metalloproteinase-2IBA 01/2016
1	Metalloproteases (Metalloproteinases)IBA 01/2016
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 01/2016
1	VemurafenibIBA 01/2016
1	Matrix Metalloproteinase InhibitorsIBA 01/2016
1	Amyloid (Amyloid Fibrils)IBA 10/2013
1	Lipoproteins (Lipoprotein)IBA 12/2011
1	IronIBA 06/2010
1	Phosphorus (Red Phosphorus)IBA 06/2010
1	ChitosanIBA 06/2010
1	AlloxanIBA 06/2010
1	PolymersIBA 06/2010
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 05/2008

Therapy/Procedure

5	Therapeutics 02/2021 - 01/2017
1	Oral Administration 01/2024
1	Drug Therapy (Chemotherapy) 09/2020
1	Aftercare (After-Treatment) 01/2016